PLOD1 and polycystic ovary syndrome: Moreover, the timing of antagonist addition did not increase the risk of early-onset LH elevation in PCOS patients (p > 0.05).So, antagonists should not be added too early for the PCOS population with high basal LH levels because of the cost and to avoid an increased number of injections.